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Inherited retinal disease leading to death of the photore-
ceptor cells affects around 1 in 3000 people and includes
the retinal ciliopathies which disrupt the function of pro-
teins associated with the photoreceptor cilia. We are
interested in the potential for repair of the retina and
preservation of sight via cell transplantation. This
approach could be broadly applicable across a range of
inherited retinal dystrophies. Our work has identified an
optimal donor cell population from the developing retina,
that following subretinal transplantation in adult mice
generates large numbers of new functional rod photore-
ceptors [1]. Although retinal neurogenesis ceases soon
after birth, successful integration and differentiation of
new rod cells can be achieved within the adult retina by
transplanting immature post mitotic cells already com-
mitted to a photoreceptor fate. This same type of photo-
receptor precursor cell can be isolated from 3D
embryonic stem cell-derived retinal differentiation cul-
tures and successfully transplanted into mouse models of
retinal disease [2]. Thus, pluripotent stem cell lines offer
the potential to generate unlimited quantities of photore-
ceptor precursor cells for retinal repair and restoration of
vision. Current and future challenges for the develop-
ment of photoreceptor cell replacement therapies for ret-
inal disease will be discussed.
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